Zobrazeno 1 - 10
of 258
pro vyhledávání: '"SZ Usmani"'
Autor:
SZ Usmani, JG Berdeja, A Jakubowiak, M Agha, AD Cohen, D Madduri, P Hari, T Yeh, Y Olyslager, A Banerjee, CC Jackson, A Allred, E Zudaire, W Deraedt, X Wu, L Pacaud, M Akram, Y Lin, T Martin, S Jagannath
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S272- (2021)
Objectives: CARTITUDE-1 (NCT03548207) is a phase 1b/2 study of ciltacabtagene autoleucel (cilta-cel; JNJ-68284528), a chimeric antigen receptor T cell (CAR-T) therapy with two B-cell maturation antigen (BCMA)–targeting single-domain antibodies, in
Externí odkaz:
https://doaj.org/article/cdf353edbb4b462faac9e5d6fe3bb822
Autor:
F Gay, JG Berdeja, V De Stefano, P Hari, B Hooper, A Haltner, S Kumar, T Martin, M-V Mateos, P Moreau, E Rosta, IA Samjoo, SZ Usmani, K Weisel, CC Jackson, Y Olyslager, JM Schecter, M Vogel, A Garrett, S Lee, T Nesheiwat, L Pacaud, C Zhou, S Valluri, LJ Costa, Y Lin
Publikováno v:
HemaSphere, Vol 6, Pp 8-8 (2022)
Externí odkaz:
https://doaj.org/article/445123a5f60b4b129eaca5ec2eef6c4c
Autor:
MA Dimopoulos, A Oriol, H Nahi, J San-Miguel, NJ Bahlis, SZ Usmani, N Rabin, RZ Orlowski, K Suzuki, T Plesner, SS Yoon, D Ben Yehuda, PG Richardson, H Goldschmidt, D Reece, T Ahmadi, X Qin, W Garvin Mayo, X Gai, J Carey, R Carson, P Moreau
Publikováno v:
HemaSphere, Vol 6, Pp 13-13 (2022)
Externí odkaz:
https://doaj.org/article/818f4ede131c44239f6341ffef8f73d8
Autor:
M Mateos, P Hari, N Bahlis, A Chari, NWCJ van de Donk, B Dholaria, AL Garfall, H Goldschmidt, KM Kortüm, A Krishnan, T Martin, D Morillo, A Oriol, D Reece, C Rodriguez, P Rodríguez-Otero, JF San-Miguel, SZ Usmani, R Verona, SXW Lin, TJ Prior, M Wade, B Weiss, JD Goldberg, E Askari
Publikováno v:
HemaSphere, Vol 6, Pp 9-9 (2022)
Externí odkaz:
https://doaj.org/article/ad3b9346a4e745edb088ec08c42f2d60
Autor:
T Martin, SZ Usmani, N Joseph, C Crivera, S Valluri, CC Jackson, L Cohen, S Singh, S Jagannath
Publikováno v:
Value in Health. 25:S366
Autor:
Banerjee R; Fred Hutchinson Cancer Center, SEATTLE, Washington, United States., Sexton R; Cancer Research And Biostatistics, Seattle, Washington, United States., Cowan AJ; Fred Hutchinson Cancer Research Center, Seattle, Washington, United States., Rosenberg AS; University of California, Davis School of Medicine, Sacramento, California, United States., Ailawadhi S; Mayo Clinic, Jacksonville, Florida, United States., Rajkumar SV; Mayo Clinic, United States, Rochester, Rochester, Minnesota, United States., Kumar SK; Mayo Clinic, Rochester, Minnesota, United States., Dispenzieri A; Mayo Clinic, Rochester, Minnesota, United States., Lonial S; Emory University School of Medicine, Atlanta, Georgia, United States., Durie BGM; Cedars-Sinai Outpatient Cancer Center, Los Angeles, California, United States., Richardson PG; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States., Usmani SZ; Memorial Sloan Kettering Cancer Center, New York, New York, United States., Hoering A; Cancer Reserach and Biostatistics, Seattle, Washington, United States., Orlowski RZ; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.
Publikováno v:
Blood [Blood] 2024 Sep 25. Date of Electronic Publication: 2024 Sep 25.
Autor:
Hultcrantz M; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. hultcram@mskcc.org., Hassoun H; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Korde N; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., MacLachlan K; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Mailankody S; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Patel D; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Shah UA; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Tan CR; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chung DJ; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Lahoud OB; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Landau HJ; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Scordo M; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Shah GL; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Giralt SA; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Pianko MJ; Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA., Burge M; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Barnett K; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Salcedo M; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Caple J; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Tran L; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Blaslov J; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Shekarkhand T; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Hamid S; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Nemirovsky D; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Derkach A; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Arisa O; Clinical Pharmacology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Peer CJ; Clinical Pharmacology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Figg WD; Clinical Pharmacology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Usmani SZ; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Landgren O; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Lesokhin AM; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2024 Sep 19; Vol. 14 (1), pp. 164. Date of Electronic Publication: 2024 Sep 19.
Autor:
Skerget S; Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA., Penaherrera D; Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA., Chari A; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, NY, USA., Jagannath S; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, NY, USA., Siegel DS; Hackensack University Medical Center, Hackensack, NJ, USA., Vij R; Division of Oncology, Washington University, St. Louis, MO, USA., Orloff G; Virginia Cancer Specialists, Fairfax, VA, USA., Jakubowiak A; University of Chicago Medical Center, Chicago, IL, USA., Niesvizky R; Weill Cornell Medicine, New York City, NY, USA., Liles D; Division of Hematology/Oncology, East Carolina University, Greenville, NC, USA., Berdeja J; Sarah Cannon Research Institute, Nashville, TN, USA., Levy M; Baylor Scott and White Research Institute, Dallas, TX, USA., Wolf J; Department of Medicine, UCSF Medical Center, San Francisco, CA, USA., Usmani SZ; Levine Cancer Institute, Charlotte, NC, USA., Christofferson AW; Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA., Nasser S; Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA., Aldrich JL; Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA., Legendre C; Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA., Benard B; Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA., Miller C; Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA., Turner B; Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA., Kurdoglu A; Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA., Washington M; Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA., Yellapantula V; Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA., Adkins JR; Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA., Cuyugan L; Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA., Boateng M; Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA., Helland A; Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA., Kyman S; Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA., McDonald J; Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA., Reiman R; Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA., Stephenson K; Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA., Tassone E; Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA., Blanski A; Van Andel Institute, Grand Rapids, MI, USA., Livermore B; Van Andel Institute, Grand Rapids, MI, USA., Kirchhoff M; Van Andel Institute, Grand Rapids, MI, USA., Rohrer DC; Van Andel Institute, Grand Rapids, MI, USA., D'Agostino M; Division of Hematology, AOU Città della Salute e della Scienza di Torino, University of Torino and Department of Molecular Biotechnology and Health Sciences, Torino, Italy., Gamella M; Division of Hematology, AOU Città della Salute e della Scienza di Torino, University of Torino and Department of Molecular Biotechnology and Health Sciences, Torino, Italy., Collison K; Spectrum Health, Grand Rapids, MI, USA., Stumph J; Spectrum Health, Grand Rapids, MI, USA., Kidd P; Spectrum Health, Grand Rapids, MI, USA., Donnelly A; Precision for Medicine, Flemington, NJ, USA., Zaugg B; Precision for Medicine, Flemington, NJ, USA., Toone M; InStat Services, Chatham, NJ, USA., McBride K; InStat Services, Chatham, NJ, USA., DeRome M; Multiple Myeloma Research Foundation, Norwalk, CT, USA., Rogers J; Multiple Myeloma Research Foundation, Norwalk, CT, USA., Craig D; Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA., Liang WS; Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA., Gutierrez NC; Department of Hematology, University Hospital of Salamanca, IBSAL, Cancer Research Center-IBMCC (USAL-CSIC), CIBERONC, Salamanca, Spain., Jewell SD; Van Andel Institute, Grand Rapids, MI, USA., Carpten J; Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA., Anderson KC; Dana-Farber Cancer Institute, Harvard Cancer Center, Boston, MA, USA., Cho HJ; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.; Multiple Myeloma Research Foundation, Norwalk, CT, USA., Auclair D; Multiple Myeloma Research Foundation, Norwalk, CT, USA., Lonial S; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA. sloni01@emory.edu., Keats JJ; Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA. jkeats@tgen.org.
Publikováno v:
Nature genetics [Nat Genet] 2024 Sep; Vol. 56 (9), pp. 1878-1889. Date of Electronic Publication: 2024 Aug 19.
Autor:
Hansen DK; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States., Lu X; Janssen Scientific Affairs, LLC, a Johnson & Johnson company, Horsham, PA, United States., Puglianini OC; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States., Sorensen S; Evidera, Bethesda, MD, United States., Usmani SZ; Memorial Sloan Kettering Cancer Center, New York, NY, United States., Zhang E; Evidera, Bethesda, MD, United States., Huo S; Janssen Global Services, LLC, Raritan, NJ, United States., Zhang Y; Janssen Scientific Affairs, LLC, a Johnson & Johnson company, Horsham, PA, United States., Qureshi ZP; Janssen Scientific Affairs, LLC, a Johnson & Johnson company, Horsham, PA, United States., Jagannath S; Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Aug 21; Vol. 15, pp. 1408892. Date of Electronic Publication: 2024 Aug 21 (Print Publication: 2024).
Autor:
Touzeau C; University hospital, Nantes, France., Krishnan AY; City of Hope Comprehensive Cancer Center, IRVINE, California, United States., Moreau P; Hematology, University Hospital Hôtel-Dieu, Nantes, France., Perrot A; CHU Toulouse - IUCT Oncopole, Toulouse, France., Usmani SZ; Memorial Sloan Kettering Cancer Center, New York, New York, United States., Manier S; CHU Lille, Lille, France., Cavo M; Seràgnoli Institute of Hematology; Bologna University School of Medicine, Bologna, Italy, Bologna, Italy., Martinez Chamorro C; Hospital Universitario Quiron Madrid, Pozuelo de Alarcon, Spain., Nooka AK; Emory University Winship Cancer Institute, Atlanta, Georgia, United States., Martin TG; UCSF, San Francisco, California, United States., Karlin L; Hôpital Lyon Sud, Pierre-benite, France., Leleu X; Hopital La Miletrie, Poitiers, France., Bahlis NJ; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada., Besemer B; University Hospital of Tuebingen, Tübingen, Germany., Pei L; Janssen R&D, Raritan, New Jersey, United States., Stein S; Janssen R&D US, Spring House, Pennsylvania, United States., Wang Lin SX; Janssen Research & Development, United States., Trancucci D; Janssen Research & Development, Raritan, New Jersey, United States., Verona R; Janssen Research & Development, United States., Girgis S; Janssen Research & Development, LLC, Spring House, Pennsylvania, United States., Miao X; Jazz Pharmaceuticals, BLUE BELL, Pennsylvania, United States., Uhlar C; Janssen R&D, Springhouse, Pennsylvania, United States., Chastain K; Janssen Research & Development, LLC, Spring House, Pennsylvania, United States., Garfall A; University of Pennsylvania, Philadelphia, Pennsylvania, United States.
Publikováno v:
Blood [Blood] 2024 Aug 20. Date of Electronic Publication: 2024 Aug 20.